Exploring the NK cell platform for cancer immunotherapy
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,263
total citations
- FWCI
- 52.63
- Percentile
- 100%
- References
- 157
Citations per year
Authors
2Topics & keywords
Topics
Keywords
- NK-92
- Lymphokine-activated killer cell
- Interleukin 21
- Immunotherapy
- Cancer immunotherapy
- Interleukin 12
- Immunology
- Janus kinase 3
UN Sustainable Development Goals
- Industry, innovation and infrastructure
No related works found for this paper.